by Greg Castanias | Nov 29, 2017 | Final Written Decisions, PTAB News
By Greg Castanias, John Marlott, and Dave Cochran In a closely followed case before the U.S. Supreme Court on behalf of SAS Institute Inc., a cross-office, cross-practice Jones Day team has challenged the Patent Trial and Appeal Board’s (PTAB) practice to elect to...
by Matthew Johnson | Nov 16, 2017 | PTAB News
By Matt Johnson On November 14th, the USPTO issued a final rule setting and adjusting patent fees during fiscal year 2017. The new fees, set to take effect January 16, 2018, include upward adjustments of fees for requesting Inter Partes Review (IPR) and...
by Carl Kukkonen | Nov 10, 2017 | PTAB News
By Jeff Giering, Ph.D. and Carl Kukkonen In an opinion dated October 12, 2017, the U.S. District Court for the Eastern District of Wisconsin granted a motion in limine to exclude evidence that a challenged patent had survived twenty post-issuance proceedings,...
by Matthew Johnson | Nov 7, 2017 | PTAB News, Trial Institution
On October 24th, the PTAB issued the following notice, designating the following decisions, which address 35 U.S.C. § 325(d), as informative. Unified Patents, Inc. v. Berman, Case IPR2016-01571 (PTAB Dec. 14, 2016) (Paper 10) In this decision, the Board denied...
by Joe Sauer | Nov 7, 2017 | 325(d) issues, PTAB News, Trial Institution
by Seth M. Bostrom and Joseph M. Sauer The Patent Trial and Appeal Board (PTAB) recently designated as informative three cases involving discretionary denial of inter partes review under 35 U.S.C. § 325(d). We previously profiled the case of Hospira, Inc. v....
by S. Christian Platt | Oct 30, 2017 | Amendment Practice, PTAB News, Time Limits
By: Christian Platt and Richard Graham The PTAB may, where good cause exists, extend a trial up to six months beyond the required twelve month length pursuant to 35 U.S.C. §316(a)(11). On October 5, 2017, the PTAB issued its first “good cause” extension of a trial in...
